GLP-1 Receptor Agonist Market Size The global GLP-1 receptor agonist market size was valued at USD 24.4 billion in 2023 and is expected to grow at 9.7% CAGR from 2024 to 2032, driven by rising incidences of type 2 diabetes and obesity globally
Each month, this report provides insight into how the behaviors and attitudes of GLP-1 (e.g., Ozempic, Wegovy, etc.) users are transforming and how theyre impacting a range of industries from healthcare to retail, food service, fitness, apparel, and even travel
Upon binding to GLP-1R, GLP-1 triggers the activation of the G protein, which stimulates adenylyl cyclase [4]
For the millions of Americans currently taking GLP-1 medications through weekly injectionsand the many more whove been hesitant to startthis development opens new possibilities for treatment
Cancer Inst
Most side effects are transient and manageable with appropriate intervention